Posted 21 June, 2021
Codex DNA, Inc. IPO completed
IPO completed detected for ticker Nasdaq:TBIO in a 424B4 filed on 21 June, 2021.
This is our initial public offering, and no public market currently exists for our common stock.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Codex DNA, Inc.
Health Care/Life Sciences • Biotechnology
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.Market Cap
$14.4M
View Company Details
$14.4M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.